TAKEDA
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company in Japan. The company markets its original products, such as the anti-prostatic cancer agent leuprolide acetate (marketed as Lupron Depot, Enantone, Prostap, and Leuplin), the anti-peptic ulcer agent lansoprazole (marketed as Prevacid, Ogast, Takepron, and other names), the anti-hypertensive agent candesartan cilexetil (marketed as Blopress, Kenzen, and Amias), and the anti-diabetic agent pioglitazone h... ydrochloride (marketed as Actos). Segments The company operates its business in two categories, Pharmaceutical business and Other businesses. The Pharmaceutical business represents the ethical drug business and healthcare business. Other businesses include business activities involving the production and marketing of a range of products, including vitamin bulks, test reagents & clinical diagnostics, photographic chemicals, and inorganic chemicals.
TAKEDA
Industry:
Biotechnology Health Care Health Diagnostics Medical Pharmaceutical
Founded:
1781-06-12
Address:
Osaka, Osaka, Japan
Country:
Japan
Website Url:
http://www.takeda.com
Total Employee:
10001+
Status:
Active
Contact:
(816) 620-4211
Total Funding:
57.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Domain Not Resolving Sitelinks Search Box Organization Schema IPv6 ReCAPTCHA
Similar Organizations
Jaber Ibn Hayyan Pharmaceutical
Jaber Ibn Hayyan Pharmaceutical manufactures drugs like anti-biotic, non-antibiotic , topical, oral and others.
Mayne Pharma
Mayne Pharma Group, a specialist pharmaceutical company, optimizes and delivers oral drugs.
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is a pharmaceutical company specializing in the development, production and marketing of generic.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2022-01-10 | Adaptate Biotherapeutics | Adaptate Biotherapeutics acquired by Takeda | N/A |
2021-03-09 | Maverick Therapeutics | Maverick Therapeutics acquired by Takeda | N/A |
2020-02-26 | PvP Biologics | PvP Biologics acquired by Takeda | 330 M USD |
2018-04-25 | Shire | Shire acquired by Takeda | 62 B GBP |
2018-01-05 | TiGenix | TiGenix acquired by Takeda | 520 M EUR |
2017-01-09 | ARIAD Pharmaceuticals | ARIAD Pharmaceuticals acquired by Takeda | 5.2 B USD |
2013-05-07 | Inviragen | Inviragen acquired by Takeda | N/A |
2012-10-05 | LigoCyte Pharmaceuticals | LigoCyte Pharmaceuticals acquired by Takeda | 60 M USD |
2011-12-21 | Intellikine | Intellikine acquired by Takeda | 310 M USD |
2011-05-19 | Nycomed Pharma | Nycomed Pharma acquired by Takeda | 9.6 B EUR |
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Takeda
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-12-21 | Ambys Medicines | Takeda investment in Series A - Ambys Medicines | 47 M USD |
2021-10-27 | Cardurion Pharmaceuticals | Takeda investment in Series B - Cardurion Pharmaceuticals | 300 M USD |
2020-11-13 | Bridge Medicines | Takeda investment in Venture Round - Bridge Medicines | 10 M USD |
2020-10-06 | xFOREST Therapeutics | Takeda investment in Seed Round - xFOREST Therapeutics | N/A |
2020-06-25 | ENTEROME | Takeda investment in Series E - ENTEROME | 46.3 M EUR |
2019-12-19 | Turnstone Biologics | Takeda investment in Corporate Round - Turnstone Biologics | N/A |
2018-10-17 | Avidity Biosciences | Takeda investment in Series B - Avidity Biosciences | 16 M USD |
2018-08-08 | Ambys Medicines | Takeda investment in Corporate Round - Ambys Medicines | 80 M USD |
2018-07-17 | GEXVal | Takeda investment in Series A - GEXVal | 410 M JPY |
2018-06-25 | Reborna Biosciences | Takeda investment in Seed Round - Reborna Biosciences | 256 M JPY |
Newest Events participated
Official Site Inspections
http://www.takeda.com Semrush global rank: 138.27 K Semrush visits lastest month: 641.67 K
- Host name: afe41c95a9e82f02c.awsglobalaccelerator.com
- IP address: 76.223.3.151
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108